Martin Torp Rahbek

Martin Torp Rahbek is a PhD Fellow at the Institute for Health Services Research within the University of Southern Denmark. His work focuses on clinical pharmacology, pharmacoepidemiology, and environmental medicine, with particular emphasis on drug safety analysis and real-world evidence generation.

• Primary Affiliation: University of Southern Denmark, Institute for Health Services Research

Research Themes:
His research spans drug safety methodologies (sequence symmetry analysis, incidence rate ratios), metabolic disorders (GLP-1 receptor agonists, insulin resistance), and multimorbidity management in diabetes patients. Recent work explores collateral drug benefits and adverse effects through Danish health registry data.

Publication Trends:
Recent publications (2024-2025) demonstrate methodological rigor in pharmacoepidemiological techniques and applied research on diabetes care interventions. Key topics include compatibility intervals, hypereosinophilia risks, and multidisciplinary team approaches for complex patient populations.

Laboratory & Collaborations:
Works within the Clinical Pharmacology, Pharmacy and Environmental Medicine research group at SDU, collaborating with multidisciplinary teams across Denmark on diabetes and multimorbidity studies.